Lodonal (naltrexone low dose oral) / Biostax Corp, Statera BioPharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

11 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
ACTRN12617000274370p: Does naltrexone reduce pain or disability after a whiplash?

Not yet recruiting
2
40
 
Notre Dame University Australia, Joondalup Health Campus
whiplash injury ; whiplash associated disorder
 
 
ACTRN12617000274370: Does naltrexone reduce pain or disability after a whiplash?

Not yet recruiting
2
40
 
Notre Dame University Australia, Joondalup Health Campus
whiplash injury , whiplash associated disorder
 
 
2005-005679-13: An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis.

Ongoing
2
40
Europe
Capsule, hard
OSPEDALE S. RAFFAELE
multiple sclerosis
 
 
2019-000852-32: A preliminary study of Low Dose Naltrexone for the induction of remission in patients with mild to moderate Crohn’s Disease that failed conventional treatment: The LDN Crohn study.

Not yet recruiting
2
122
Europe
Naltrexone hydrochloride, Tablet
ErasmusMC, ZonMw, ErasmusMC
Inflammatory Bowel Disease, Crohn's disease De ziekte van Crohn, Inflammatory Bowel Disease, Crohn's disease, Diseases [C] - Digestive System Diseases [C06]
 
 
2022-000245-33: To evaluate the effect of low-dose naltrexone (LDN) on pain perception and quality of life in women Ocena wpływu niskich dawek Naltreksonu (LDN) na odczuwanie bólu i jakość życia kobiet z wulwodynią

Not yet recruiting
2
300
Europe
naltrexone, Coated tablet
Medical University of Lublin, Medical Research Agency
Vulvodynia, Chronic pain in the vulva, the area on the outside of a woman's genitals., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
NCT04450316: Low-dose Naltrexone for Bladder Pain Syndrome

Suspended
2
40
US
Naltrexone, Placebo
Stanford University
Bladder Pain Syndrome, Interstitial Cystitis
07/24
10/24
LoDoNaVasc, NCT03482479: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Recruiting
2
36
Canada, US
Naltrexone Hydrochloride, Placebo Comparator
University of Pennsylvania
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu Arteritis
12/24
12/24
NCT05430152: Low-dose Naltrexone for Post-COVID Fatigue Syndrome

Recruiting
2
160
Canada
Low-Dose Naltrexone, LDN, Placebo
Luis Nacul, BC Women's Hospital & Health Centre, University of British Columbia, Canadian Institutes of Health Research (CIHR), Provincial Health Services Authority
Post-Viral Fatigue Syndrome
12/24
12/24
LIFT, NCT06366724: Life Improvement Trial

Not yet recruiting
2
160
NA
Pyridostigmine, Mestinon, Low-Dose Naltrexone, LDN, Placebo
Brigham and Women's Hospital, Open Medicine Foundation
ME/CFS
03/26
06/26
NCT04678895: Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

Recruiting
2
35
US
Naltrexone, LDN, Placebo
Dartmouth-Hitchcock Medical Center
Painful Diabetic Neuropathy
09/25
09/25
NCT05955313: Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Recruiting
2
300
Europe
Naltrexone Hydrochloride, naltrexone
Medical University of Lublin
Vulvodynia, Naltrexone, Quality of Life
12/25
12/26

Download Options